News
12-17-2008, 08:10 AM
CANCER RESEARCH UK scientists have found that a test, already used in breast cancer diagnosis, can also predict who will and who won't benefit from commonly used chemotherapy drugs. The research shows that women who have a duplication of chromosome 17 in their tumour will benefit from anthracycline drugs, while others can be spared the side-effects of the treatment.
More... (http://www.medicalnewstoday.com/articles/133259.php)
More... (http://www.medicalnewstoday.com/articles/133259.php)